Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Asthma

Free Subscription Articles published in Respir Res Retrieve available abstracts of 100 articles: HTML format

Single Articles

April 2026
1. NIU W, Huang J, Hu Y, Tang G, et al
   Short-term effects of air pollutants on asthma hospitalizations in a megacity in North China (2016-2021): a time-series study.
   Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03620.
   PubMed    
   
   
   
2. HUGO T, Harper AR, Leander J, Gardiner P, et al
   Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
   Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613.
   PubMed    
   
   
   
3. FISCHER BC, Drick N, Liu B, Riemann L, et al
   B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.
   Respir Res. 2026 Apr 2. doi: 10.1186/s12931-026-03500.
   PubMed    
   
   
   March 2026
4. KO FWS, Chan KKP, Ng TCC, Lo RLP, et al
   A 3-year prospective study to assess clinical characteristics and risk factors for exacerbations in patients with asthma-COPD overlap based on the GINA guideline compared with patients with asthma and COPD.
   Respir Res. 2026 Mar 29. doi: 10.1186/s12931-026-03643.
   PubMed    
   
   
   
5. ZHANG M, Liu Q, Ju L, Zheng Y, et al
   Multi-omics integration identifies associations between large high-density lipoprotein and lung function, asthma, and COPD: evidence from genetic and population-based analyses.
   Respir Res. 2026 Mar 6. doi: 10.1186/s12931-026-03562.
   PubMed    
   
   
   February 2026
6. GARCIA-RIVERO JL, Hannaoui Anaaoui A, Pallares-Sanmartin A, Blanco-Aparicio M, et al
   Multidomain clinical and biological remission with tezepelumab in severe asthma: a 12-month multicentre real-world study.
   Respir Res. 2026 Feb 27. doi: 10.1186/s12931-026-03597.
   PubMed    
   
   
   
7. CHEN Y, Shen Y, Shen H, Liu Z, et al
   GLP-1RAs: antidiabetic drug crossover-new hope for chronic inflammatory airway diseases.
   Respir Res. 2026;27:144.
   PubMed     Abstract available
   
   
   
8. DEVILLIERS MA, Saber Cherif L, Brisebarre A, Chouquet R, et al
   Identification and validation of cilia-associated molecular candidates deregulated in severe asthma.
   Respir Res. 2026 Feb 9. doi: 10.1186/s12931-026-03548.
   PubMed    
   
   
   
9. XIAO Z, Shi Y, Zhao D, Wang Y, et al
   Triggering mechanisms of acute thunderstorm asthma: epithelial barrier disruption and immune dysregulation.
   Respir Res. 2026 Feb 7. doi: 10.1186/s12931-026-03532.
   PubMed     Abstract available
   
   
   
10. BOURDIN A, Canonica GW, Virchow JC, Borsos K, et al
    Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study.
    Respir Res. 2026 Feb 4. doi: 10.1186/s12931-026-03515.
    PubMed    
    
    
    January 2026
11. YAO L, Yuan X, Sun P, Fu H, et al
    Desmoglein-2 dysregulation impairs epithelial barrier integrity in eosinophilic asthma.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03510.
    PubMed    
    
    
    
12. AEGERTER H, Brightling CE, Dunican EM, Lambrecht BN, et al
    Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03501.
    PubMed     Abstract available
    
    
    
13. LASSER C, Ax E, Weidner J, Winslow S, et al
    The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.
    Respir Res. 2026;27:30.
    PubMed     Abstract available
    
    
    
14. CARELLI M, Miotti J, Zanolin ME, Bilo MB, et al
    Mediterranean diet and asthma in adults: a multicentre case-control study in a general population sample.
    Respir Res. 2026 Jan 13. doi: 10.1186/s12931-025-03484.
    PubMed    
    
    
    
15. LI X, Zhang J, Feng Y, Zhou Q, et al
    Modulation of the NF-kappaB signaling pathway by the combined strategy of tocilizumab and dexamethasone for asthma therapy.
    Respir Res. 2026 Jan 8. doi: 10.1186/s12931-025-03458.
    PubMed     Abstract available
    
    
    
16. PANETTIERI RA JR, Mohan A, Lugogo NL, Ledford DK, et al
    Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study.
    Respir Res. 2026;27:5.
    PubMed     Abstract available
    
    
    
17. SHARMA R, Kelly RS, Mendez K, Chen Q, et al
    Differences in microRNA levels across metabo-endotypes reveal novel insights into asthma heterogeneity.
    Respir Res. 2026 Jan 7. doi: 10.1186/s12931-025-03452.
    PubMed    
    
    
    December 2025
18. PIPARIA S, Kho AT, Desai B, Wong R, et al
    A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma.
    Respir Res. 2025;26:351.
    PubMed     Abstract available
    
    
    
19. LEE SE, Kim BK, Kang N, Lee Y, et al
    Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.
    Respir Res. 2025 Dec 27. doi: 10.1186/s12931-025-03451.
    PubMed     Abstract available
    
    
    
20. WANG K, Wu R, Fan M, Jia R, et al
    CPA3 drives the development of asthma by promoting the activation of the JAK/STAT6 pathway.
    Respir Res. 2025 Dec 23. doi: 10.1186/s12931-025-03456.
    PubMed    
    
    
    
21. ZHANG H, Rao Z, Liu X, Shu Y, et al
    USP18 confers protection against allergic asthma by suppressing CCL8 production in alveolar type II epithelial cells.
    Respir Res. 2025 Dec 8. doi: 10.1186/s12931-025-03433.
    PubMed     Abstract available
    
    
    November 2025
22. TAO X, Xu X, Jiang X, Chen M, et al
    Susceptibility to childhood asthma modified by the interactive effects of polycyclic aromatic hydrocarbons exposure and genetic polymorphisms of the aryl hydrocarbon receptor signaling pathway: functional analysis based on lipid metabolism.
    Respir Res. 2025 Nov 28. doi: 10.1186/s12931-025-03428.
    PubMed     Abstract available
    
    
    
23. DIXON AE, Garrow OJ, Duchene B, Martin F, et al
    A randomized trial of continuous positive airway pressure for the asthma of obesity.
    Respir Res. 2025;26:314.
    PubMed    
    
    
    
24. ABUJABAL R, Alanta TM, Alhamidi RS, Altaie AM, et al
    IL-5 signaling in asthmatic derived fibroblasts exacerbates airway remodeling through ECM dysregulation and apoptosis resistance.
    Respir Res. 2025;26:307.
    PubMed     Abstract available
    
    
    
25. MARCON A, Martinelli L, Bansal AT, Berret E, et al
    Use of long-acting muscarinic antagonists for severe asthma: insights from clinicians in the SHARP network.
    Respir Res. 2025;26:306.
    PubMed     Abstract available
    
    
    October 2025
26. KELSEN SG, Maurer M, Waters M, Dash A, et al
    Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.
    Respir Res. 2025;26:302.
    PubMed     Abstract available
    
    
    
27. NOPSOPON T, Cabrera-Perez J, Lee PY, Brodeur KE, et al
    Impact of clinical factors and season on inflammatory cytokines in biologic-treated and untreated asthma.
    Respir Res. 2025;26:291.
    PubMed     Abstract available
    
    
    
28. CHENG WH, Chang WS, Feng PH, Chen KY, et al
    Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma.
    Respir Res. 2025;26:288.
    PubMed     Abstract available
    
    
    
29. FOO CT, Langton D, Donovan GM, Thompson BR, et al
    Bronchial thermoplasty reduces ventilation heterogeneity measured by phase-resolved functional lung magnetic resonance imaging in severe asthma.
    Respir Res. 2025;26:290.
    PubMed     Abstract available
    
    
    August 2025
30. YUAN D, Yang X, He B, Han Y, et al
    Yanghe Pingchuan granules inhibit cellular senescence in airway smooth muscle cells to improve bronchial asthma via modulating Nrf2 acetylation.
    Respir Res. 2025;26:266.
    PubMed     Abstract available
    
    
    July 2025
31. KUNTZMAN K, Hakansson KEJ, Ulrik CS, Rastogi D, et al
    Impact of natal and childhood metabolic markers on childhood asthma burden - a nationwide cohort study.
    Respir Res. 2025;26:246.
    PubMed     Abstract available
    
    
    
32. WANG S, Kun T, Tian Z, Huang M, et al
    The MFGE8/integrin beta3 axis mitigates experimental neutrophilic asthma by suppressing NLRP3-Caspase-1 pathway-mediated NETosis.
    Respir Res. 2025;26:229.
    PubMed     Abstract available
    
    
    
33. KHALFAOUI L, Moore RM, Villasboas JC, Whitaker KR, et al
    Spatial phenotyping of human bronchial airways in obstructive lung disease.
    Respir Res. 2025;26:232.
    PubMed     Abstract available
    
    
    
34. DOSANJH DPS, Darrah E, Jensen TJ, Jevnikar Z, et al
    ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.
    Respir Res. 2025;26:233.
    PubMed     Abstract available
    
    
    June 2025
35. WANG D, Liu C, Bao C, Hu J, et al
    Inhibition of the ATP synthase c subunit ameliorates HDM/LPS-induced inflammatory responses in asthmatic bronchial epithelial cells by blocking the mPTP-mtDNA-cGAS-STING axis.
    Respir Res. 2025;26:219.
    PubMed     Abstract available
    
    
    
36. NJOROGE M, Pinheiro GP, Santana CVN, Ali H, et al
    Causes and MEchanisms foR non-atopic Asthma in Children (CAMERA) study: rationale and protocol.
    Respir Res. 2025;26:212.
    PubMed     Abstract available
    
    
    
37. TAYLOR SL, Brooks CR, Elms L, Manning SK, et al
    Sputum quality affects assessment of airway microbiology in childhood asthma.
    Respir Res. 2025;26:209.
    PubMed     Abstract available
    
    
    May 2025
38. ZHAO L, Wu W, Chen G, Huang C, et al
    SERPINB10 promotes macrophage M2 polarization and airway inflammation in asthma.
    Respir Res. 2025;26:181.
    PubMed     Abstract available
    
    
    
39. TIAN J, Zhang Q, Peng M, Guo L, et al
    Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study.
    Respir Res. 2025;26:173.
    PubMed     Abstract available
    
    
    April 2025
40. JIANG H, Jiang Y, Dong R, Fu CY, et al
    ETS2 aggravate allergic airway inflammation by regulating ANT2-mediated cytosolic mitochondrial DsRNA levels.
    Respir Res. 2025;26:159.
    PubMed     Abstract available
    
    
    
41. PINKSTON RI, Schexnayder M, Perveen Z, Langohr IM, et al
    MMP12 deficiency attenuates menthol e-cigarette plus house dust-mite effects on pulmonary iron homeostasis and oxidative stress.
    Respir Res. 2025;26:135.
    PubMed     Abstract available
    
    
    
42. AHN SY, Ho TL, Ko EJ
    Evaluation of the influenza vaccine protection in the house dust mite-induced chronic allergic asthma mice model and the evaluation of squalene oil in water emulsion as an adjuvant candidate.
    Respir Res. 2025;26:132.
    PubMed     Abstract available
    
    
    
43. ZHANG J, Luo W, Cui Y, Sun B, et al
    B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model.
    Respir Res. 2025;26:129.
    PubMed     Abstract available
    
    
    
44. CONLEY HE, Davis KU, Adler KB, Lavoie JP, et al
    MARCKS protein is a potential target in a naturally occurring equine model of neutrophilic asthma.
    Respir Res. 2025;26:126.
    PubMed     Abstract available
    
    
    March 2025
45. GOODALL E, Rothnie KJ, Numbere B, Zhang S, et al
    Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study.
    Respir Res. 2025;26:121.
    PubMed     Abstract available
    
    
    
46. ADLER A, Bergwik J, Padra M, Papareddy P, et al
    Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.
    Respir Res. 2025;26:101.
    PubMed     Abstract available
    
    
    February 2025
47. BERTOLINI F, Carriero VMA, Arrigo E, Guida G, et al
    Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.
    Respir Res. 2025;26:78.
    PubMed     Abstract available
    
    
    
48. WARDEN DE, Zhang H, Jiang Y, Arshad HS, et al
    The role of wheezing subtypes in the development of early childhood asthma.
    Respir Res. 2025;26:79.
    PubMed     Abstract available
    
    
    
49. LIN G, Wei Y, Guo Z, Wang H, et al
    Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.
    Respir Res. 2025;26:75.
    PubMed     Abstract available
    
    
    
50. LI N, Xu Y, Xiao X, Ding Z, et al
    Long-term trends in the burden of asthma in China: a joinpoint regression and age-period-cohort analysis based on the GBD 2021.
    Respir Res. 2025;26:56.
    PubMed     Abstract available
    
    
    
51. GUO Y, Zhou Y, Wang R, Lin Y, et al
    YAP as a potential therapeutic target for myofibroblast formation in asthma.
    Respir Res. 2025;26:51.
    PubMed     Abstract available
    
    
    
52. WANG Z, Zhao P, Yan G, Sun A, et al
    Neuropeptide S and its receptor aggravated asthma via TFEB dependent autophagy in bronchial epithelial cells.
    Respir Res. 2025;26:50.
    PubMed     Abstract available
    
    
    
53. LUO T, Ji W, Gong Y, Chen L, et al
    REDD1 mediates HDM-induced nuclear-cytoplasmic translocation and release of IL-33 in airway epithelial cells by downregulating Nrf2.
    Respir Res. 2025;26:47.
    PubMed     Abstract available
    
    
    January 2025
54. DE VOLDER J, Bontinck A, Haelterman V, Boon L, et al
    Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.
    Respir Res. 2025;26:43.
    PubMed     Abstract available
    
    
    
55. MOORE CM, Thornburg J, Secor EA, Hamlington KL, et al
    Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children.
    Respir Res. 2025;26:40.
    PubMed     Abstract available
    
    
    
56. TIWARI A, Hobbs BD, Sharma R, Li J, et al
    Peripheral blood miRNAs are associated with airflow below threshold in children with asthma.
    Respir Res. 2025;26:38.
    PubMed     Abstract available
    
    
    
57. CHEN X, Shang Y, Shen D, Shi S, et al
    Potential drug targets for asthma identified through mendelian randomization analysis.
    Respir Res. 2025;26:16.
    PubMed     Abstract available
    
    
    
58. PARK HS, Lee J, Kim H, Woo SD, et al
    Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management.
    Respir Res. 2025;26:12.
    PubMed     Abstract available
    
    
    
59. MISIUKIEWICZ-STEPIEN P, Zajusz-Zubek E, Gorska K, Krenke R, et al
    The different response of PM(2.5) stimulated nasal epithelial spheroids in control, asthma and COPD groups.
    Respir Res. 2025;26:8.
    PubMed     Abstract available
    
    
    December 2024
60. FAINARDI V, Grandinetti R, Mussi N, Rossi A, et al
    Exercise-induced bronchoconstriction in children: Delphi study and consensus document about definition and epidemiology, diagnostic work-up, treatment, and follow-up.
    Respir Res. 2024;25:445.
    PubMed     Abstract available
    
    
    
61. TANG H, Li Z, Yang C, Fu L, et al
    CTSS contributes to airway neutrophilic inflammation in mixed granulocytic asthma.
    Respir Res. 2024;25:441.
    PubMed     Abstract available
    
    
    
62. RAO X, Luo H, Luo K, Hu C, et al
    Silencing SMAD4 inhibits inflammation and ferroptosis in asthma by blocking the IL-17A signaling pathway.
    Respir Res. 2024;25:429.
    PubMed     Abstract available
    
    
    November 2024
63. FAN R, Qian H, Xu JY, Wang JY, et al
    Association of asthma and bronchiectasis: Mendelian randomization analyses and observational study.
    Respir Res. 2024;25:413.
    PubMed     Abstract available
    
    
    October 2024
64. AMBHORE NS, Balraj P, Kumar A, Reza MI, et al
    Kiss1 receptor knockout exacerbates airway hyperresponsiveness and remodeling in a mouse model of allergic asthma.
    Respir Res. 2024;25:387.
    PubMed     Abstract available
    
    
    
65. MCDUFFIE EL, Panettieri RA Jr, Scott CP
    Correction to: G(12/13) signaling in asthma.
    Respir Res. 2024;25:371.
    PubMed    
    
    
    
66. LIU Y, Yin Q, Liu B, Lu Z, et al
    Fisetin reduces ovalbumin-triggered airway remodeling by preventing phenotypic switching of airway smooth muscle cells.
    Respir Res. 2024;25:370.
    PubMed     Abstract available
    
    
    
67. GOETEYN E, Taylor SL, Dicker A, Bolle L, et al
    Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.
    Respir Res. 2024;25:368.
    PubMed     Abstract available
    
    
    
68. CAMINATI M, Vatrella A, Rogliani P, Carpagnano E, et al
    Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
    Respir Res. 2024;25:367.
    PubMed     Abstract available
    
    
    September 2024
69. EL ABD A, Dasari H, Dodin P, Trottier H, et al
    Associations between vitamin D status and biomarkers linked with inflammation in patients with asthma: a systematic review and meta-analysis of interventional and observational studies.
    Respir Res. 2024;25:344.
    PubMed     Abstract available
    
    
    
70. BONNESEN B, Eklof J, Biering-Sorensen T, Modin D, et al
    Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis.
    Respir Res. 2024;25:339.
    PubMed     Abstract available
    
    
    August 2024
71. ZHANG D, Pu X, Zheng M, Li G, et al
    Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes.
    Respir Res. 2024;25:327.
    PubMed     Abstract available
    
    
    
72. ALLARD B, Ousova O, Savitskaya Z, Levardon H, et al
    Pulmonary adaptation to repeated poly(I:C) exposure is impaired in asthmatic mice: an observational study.
    Respir Res. 2024;25:314.
    PubMed     Abstract available
    
    
    
73. OUYANG S, Lu P, Li J, Jin H, et al
    Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation.
    Respir Res. 2024;25:311.
    PubMed     Abstract available
    
    
    
74. GAO F, Lei J, Zhu H, Zhao L, et al
    Small airway dysfunction links asthma exacerbations with asthma control and health-related quality of life.
    Respir Res. 2024;25:306.
    PubMed     Abstract available
    
    
    
75. PATEL A, Buszkiewicz JH, Cook S, Arenberg DA, et al
    Longitudinal association of exclusive and dual use of cigarettes and cigars with asthma exacerbation among US adults: a cohort study.
    Respir Res. 2024;25:305.
    PubMed     Abstract available
    
    
    
76. SUGAWARA H, Saito A, Yokoyama S, Chiba H, et al
    Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry.
    Respir Res. 2024;25:300.
    PubMed     Abstract available
    
    
    
77. MCDUFFIE EL, Panettieri RA Jr, Scott CP
    G(12/13) signaling in asthma.
    Respir Res. 2024;25:295.
    PubMed     Abstract available
    
    
    July 2024
78. GU W, Huang C, Chen G, Kong W, et al
    The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma.
    Respir Res. 2024;25:290.
    PubMed     Abstract available
    
    
    
79. WAN M, Yu Q, Xu F, You LX, et al
    Novel hypoxia-induced HIF-1alphaactivation in asthma pathogenesis.
    Respir Res. 2024;25:287.
    PubMed     Abstract available
    
    
    
80. VINCENT-GALTIE N, Marquant Q, Catherinot E, Ackermann F, et al
    Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.
    Respir Res. 2024;25:272.
    PubMed     Abstract available
    
    
    
81. LIU X, Zhang J, Zhang D, Pan Y, et al
    Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.
    Respir Res. 2024;25:271.
    PubMed     Abstract available
    
    
    June 2024
82. ZENG R, Zhang D, Zhang J, Pan Y, et al
    Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway.
    Respir Res. 2024;25:230.
    PubMed     Abstract available
    
    
    May 2024
83. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
    Objective monitoring tools for improved management of childhood asthma.
    Respir Res. 2024;25:194.
    PubMed     Abstract available
    
    
    April 2024
84. SHARMA E, Lauten K, Zebrak KA, Edwards KC, et al
    Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).
    Respir Res. 2024;25:185.
    PubMed     Abstract available
    
    
    
85. XIANG J, Liu B, Li Y, Ren Y, et al
    TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
    Respir Res. 2024;25:182.
    PubMed     Abstract available
    
    
    
86. FARINHA I, Heaney LG
    Barriers to clinical remission in severe asthma.
    Respir Res. 2024;25:178.
    PubMed     Abstract available
    
    
    
87. PINKERTON JW, Preite S, Piras A, Zervas D, et al
    PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
    Respir Res. 2024;25:175.
    PubMed     Abstract available
    
    
    
88. WAN R, Srikaram P, Xie S, Chen Q, et al
    PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
    Respir Res. 2024;25:174.
    PubMed     Abstract available
    
    
    
89. LIU Y, Chen F, Zeng Z, Lei C, et al
    Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
    Respir Res. 2024;25:171.
    PubMed     Abstract available
    
    
    
90. KOVACH MA, Kack U, Che KF, Brundin B, et al
    Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
    Respir Res. 2024;25:163.
    PubMed     Abstract available
    
    
    
91. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
    Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
    Respir Res. 2024;25:161.
    PubMed     Abstract available
    
    
    March 2024
92. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
    A novel quinoline with airway relaxant effects and anti-inflammatory properties.
    Respir Res. 2024;25:146.
    PubMed     Abstract available
    
    
    
93. LU L, Wu F, Peng J, Wu X, et al
    Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
    Respir Res. 2024;25:149.
    PubMed     Abstract available
    
    
    
94. HSU YT, Wu CC, Wang CC, Sheu CC, et al
    Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
    Respir Res. 2024;25:139.
    PubMed     Abstract available
    
    
    
95. MEI S, Li D, Wang A, Zhu G, et al
    The role of sialidase Neu1 in respiratory diseases.
    Respir Res. 2024;25:134.
    PubMed     Abstract available
    
    
    
96. HONG X, Jiang M, Kho AT, Tiwari A, et al
    Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
    Respir Res. 2024;25:118.
    PubMed     Abstract available
    
    
    
97. CAI R, Gong X, Li X, Jiang Y, et al
    Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
    Respir Res. 2024;25:119.
    PubMed     Abstract available
    
    
    
98. LAN G, Xie M, Lan J, Huang Z, et al
    Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
    Respir Res. 2024;25:115.
    PubMed     Abstract available
    
    
    February 2024
99. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
    The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
    Respir Res. 2024;25:104.
    PubMed     Abstract available
    
    
    
100. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
     Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
     Respir Res. 2024;25:99.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum